trending Market Intelligence /marketintelligence/en/news-insights/trending/bCU4RqQCZEUTU67acTHLRQ2 content esgSubNav
In This List

Mylan launches generic version of EpiPen

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Mylan launches generic version of EpiPen

Mylan NV launched an authorized generic for its EpiPen Auto-Injector at $300 for a pack of two injections.

The generic product has the same drug formulation and device functionality as EpiPen and will reach retail pharmacies in the week of Dec. 19.